Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
|Articles|April 30, 2019
How to Use Antidepressants in Bipolar II
Author(s)Chris Aiken, MD
Podcast: Treatment strategies on a long-debated issue, 18 experts reveal what they really do in practice.
Advertisement
Podcast: Treatment strategies on a long-debated issue, 18 experts reveal what they really do in practice. For more on this topic, see
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Food Noise and GLP-1 Drugs: What Research Reveals About Motivation and Appetitive Drive
2
Burnout, Gratitude, and the Value of Staying Current: On the Mind of Gus Alva, MD, DFAPA
3
Dementia Pipeline Update: Phase 2 and 3 Developments in Alzheimer Disease and Lewy Body Dementia
4
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders
5